BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11467379)

  • 1. Computed tomographic staging of esophageal cancer and prognosis.
    Ampil FL; Caldito G; Li BD; Pelser R
    Radiat Med; 2001; 19(3):127-9. PubMed ID: 11467379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.
    Kato H; Miyazaki T; Nakajima M; Takita J; Kimura H; Faried A; Sohda M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Cancer; 2005 Jan; 103(1):148-56. PubMed ID: 15558794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleolar organizer regions (NORs) as a prognostic factor in patients with squamous-cell oesophageal cancer.
    Dabrowski A; Szumiło J; Ciechański A; Ciechańska M; Wallner G
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():53-62. PubMed ID: 11205807
    [No Abstract]   [Full Text] [Related]  

  • 4. Preoperative staging of esophageal carcinoma with multidetector CT and virtual endoscopy.
    Onbaş O; Eroglu A; Kantarci M; Polat P; Alper F; Karaoglanoglu N; Okur A
    Eur J Radiol; 2006 Jan; 57(1):90-5. PubMed ID: 16122893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal carcinoma: pretherapy staging by computed tomography.
    Moss AA; Schnyder P; Thoeni RF; Margulis AR
    AJR Am J Roentgenol; 1981 Jun; 136(6):1051-6. PubMed ID: 6786011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor volume as outcome determinant in patients treated with chemoradiation for locally advanced esophageal cancer.
    Créhange G; Bosset M; Lorchel F; Buffet-Miny J; Dumas JL; Mercier M; Puyraveau M; Maingon P; Bosset JF
    Am J Clin Oncol; 2006 Dec; 29(6):583-7. PubMed ID: 17148995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of mini-probe endoscopic ultrasonography with computed tomography in preoperative staging of esophageal cancer].
    Hu H; Xiang JQ; Zhang YW; Chen J; Gu YJ; Miao LS; Ma LF
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):123-6. PubMed ID: 16750017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Computed tomography of esophageal carcinoma. Correlation between computed tomographic and postoperative findings].
    Mühling T; Kuklinski ME; Hübsch T; Witte J
    Rofo; 1985 Aug; 143(2):189-93. PubMed ID: 2992035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of computed tomography for the pretherapeutic staging of esophageal cancer].
    Rotte KH; Kriedemann E; Geyer J; Perlick E
    Radiol Diagn (Berl); 1989; 30(2):111-7. PubMed ID: 2740477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staging esophageal carcinoma II: CT and MRI.
    Thompson WM; Halvorsen RA
    Semin Oncol; 1994 Aug; 21(4):447-52. PubMed ID: 8042043
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography in the staging of esophageal cancer.
    Leccisotti L
    Rays; 2006; 31(1):9-12. PubMed ID: 16999368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
    Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic CT in patients with esophageal cancer.
    Gollub MJ; Lefkowitz R; Moskowitz CS; Ilson D; Kelsen D; Felderman H
    AJR Am J Roentgenol; 2005 Feb; 184(2):487-90. PubMed ID: 15671368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of computed tomography in preoperative evaluation of resectability and staging in oesophageal carcinoma.
    Søndenaa K; Skaane P; Nygaard K; Skjennald A
    Eur J Surg; 1992 Oct; 158(10):537-40. PubMed ID: 1360825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.
    Nomura M; Shitara K; Kodaira T; Hatooka S; Mizota A; Kondoh C; Yokota T; Takahari D; Ura T; Muro K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):946-52. PubMed ID: 21362578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endoesophageal ultrasonography in the staging of esophageal carcinoma].
    Mineo TC; Francioni F; Biancari F; Casciani CU
    Minerva Chir; 1996 Oct; 51(10):773-8. PubMed ID: 9082204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinico-surgical correlation of axial computed tomography in the extension of gastric and esophageal cancer].
    Silva JJ; Csendes A; Passalacqua H; Ruiz F
    Rev Med Chil; 1986 Aug; 114(8):748-51. PubMed ID: 3575958
    [No Abstract]   [Full Text] [Related]  

  • 19. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging.
    Erasmus JJ; Munden RF; Truong MT; Ho JJ; Hofstetter WL; Macapinlac HA; Correa AM; Wu TT; Bruzzi JF; Marom EM; Sabloff BS; Ajani JA; Komaki R; Liao Z; Lee JH; Fukami N; Bresalier R; Swisher SG
    J Thorac Oncol; 2006 Jun; 1(5):478-86. PubMed ID: 17409902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.
    Kato H; Kuwano H; Nakajima M; Miyazaki T; Yoshikawa M; Ojima H; Tsukada K; Oriuchi N; Inoue T; Endo K
    Cancer; 2002 Feb; 94(4):921-8. PubMed ID: 11920459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.